Kennedy’s commitment to walk away from the potential windfall is a major reversal for the nominee, who in his ethics plan ...

Merck & Co (NYSE:MRK)., the second-largest U.S. drugmaker by revenue, is facing a jury trial over accusations that it ...

Senators had objected to the financial conflict posed by Robert F. Kennedy Jr.’s decision to retain a financial stake in ...

RFK Jr. said he would give up the fees after senators questioned him about the lawsuits in a pair of hearings.

Robert F. Kennedy Jr., Trump's pick to head the Department of Health and Human Services, faces scrutiny for fees he may earn from lawsuits against Merck.

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

If confirmed as health secretary, Robert F. Kennedy Jr. would oversee the Food and Drug Administration and other agencies ...

President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV ...

RFK Jr. played a lead role in building a case against Merck's HPV vaccine and could profit from the lawsuit alleging fraud, ...

a law firm suing Merck over claims that the pharmaceutical company failed to properly warn consumers about risks from its HPV ...

Kennedy has faced scrutiny from senators at his confirmation hearings over his plan to profit from vaccine lawsuits while ...

Discover why Merck presents a compelling long-term investment opportunity with its discounted valuation, robust pipeline, and ...